Диагностическая ценность компьютерной томографии в оценке регионарного матастазирования немелкоклеточного рака легкого, осложненного вторичным инфекционным процессом Medline.ru - медико-биологический информационный портал Медлайн.ру

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-7.

2. Cerfolio RJ, Bryant AS, Ojha B , Eloubeidi M. Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg 2005; 80(4):1207-3; discussion 1213-.

3. Knoepp UW , Ravenel JG. CT and PET imaging in non-small cell lung cancer. Crit Rev Oncol Hematol 2005.

4. Бисенков ЛН, editor. Хирургия далеко зашедших и осложненных форм рака легкого. Санкт-Петербург: Деан; 2006.

5. Lloyd C , Silvestri GA. Mediastinal staging of non-small-cell lung cancer. Cancer Control 2001; 8(4):311-7.

6. Rankin SC. Staging of non-small cell lung cancer (NSCLC). Cancer Imaging 2006; 6:1-3.

7. Bulzebruck H, Bopp R, Drings P, Bauer E, Krysa S, Probst G, van Kaick G, Muller KM , Vogt-Moykopf I. New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification. Cancer 1992; 70(5):1102-10.

8. Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL , Orringer MB. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 1985; 144(2):261-5.

9. Beckles MA, Spiro SG, Colice GL , Rudd RM. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003; 123(1 Suppl):105S-14S.

10. The R Project for Statistical Computing. Free software environment for statistical computing and graphics. http://www.r-project.org.

11. Clinical Decision Making Spreadsheet Calculator. ftp://www.fammed.ouhsc.edu/CDM/2x2p%26ci.xl4

12. Meta-DiSc. Free software to perform Meta-analysis of studies of evaluations of diagnostic and screening tests. http://www.hrc.es/investigacion/metadisc_en.htm

13. Стилиди ИС , Тер-Ованесов МД. Хирургическое лечение рака легкого. Практическая онкология 2000; 3:21-3.

14. Toloza EM, Harpole L, Detterbeck F , McCrory DC. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123(1 Suppl):157S-66S.

15. Kerr KM, Lamb D, Wathen CG, Walker WS , Douglas NJ. Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. Thorax 1992; 47(5):337-41.

16. Webb WR, Gamsu G , Birnberg FA. CT appearance of bronchial carcinoid with recurrent pneumonia and hyperplastic hilar lymphadenopathy. J Comput Assist Tomogr 1983; 7(4):707-9.

17. Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR , McNeil BJ. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178(3):705-13.

18. Daly BD, Faling LJ , Pugatch RDea. Computed tomography: an effective technique for mediastinal staging in lung cancer. Thorac Cardiovasc Surg 1984; 88:486-94.

19. Arita T, Kuramitsu T, Kawamura M, Matsumoto T, Matsunaga N, Sugi K , Esato K. Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes. Thorax 1995; 50(12):1267-9.

20. Arita T, Matsumoto T, Kuramitsu T, Kawamura M, Matsunaga N, Sugi K , Esato K. Is it possible to differentiate malignant mediastinal nodes from benign nodes by size Reevaluation by CT, transesophageal echocardiography, and nodal specimen. Chest 1996; 110(4):1004-8.

21. Satoh H, Ishikawa H, Yamashita YT, Ohtsuka M , Sekizawa K. Metastatic lung cancer without regional lymph node swelling. Chest 2001; 120(2):689-90.

22. Dwamena BA, Sonnad SS, Angobaldo JO , Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. Radiology 1999; 213(2):530-6.

23. Muller NL , Nichols DM. Accuracy of the plain radiograph in the detection of aortopulmonary lymphadenopathy. Can Assoc Radiol J 1987; 38(2):82-6.

24. Toloza EM, Harpole L , McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123(1 Suppl):137S-46S.

25. Dunagan D, Chin RJ, McCain T, Case L, Harkness B, Oaks T , Haponik E. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. Chest 2001; 119(2):333-9.

26. Kamiyoshihara M, Kawashima O, Ishikawa S , Morishita Y. Mediastinal lymph node evaluation by computed tomographic scan in lung cancer. J Cardiovasc Surg (Torino) 2001; 42(1):119-24.

27. Osada H, Kojima K, Tsukada H, Nakajima Y, Imamura K , Matsumoto J. Costeffectiveness associated with the diagnosis and staging of non-small-cell lung cancer. Jpn J Thorac Cardiovasc Surg 2001; 49(1):1-10.

28. Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, Fidler V, Pruim J , Groen HJ. Preoperative staging of non-small-cell lung cancer with positronemission tomography. N Engl J Med 2000; 343(4):254-61.

29. Takamochi K, Nagai K, Yoshida J, Suzuki K, Ohde Y, Nishimura M, Takahashi K , Nishiwaki Y. The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer. J Thorac Cardiovasc Surg 2000; 119(6):1135-40.

30. Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE , Patz EFJ. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212(3):803-9.

31. Saunders CA, Dussek JE, O'Doherty MJ , Maisey MN. Evaluation of fluorine-18fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg 1999; 67(3):790-7.

32. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K , Nishiwaki Y. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 1999; 117(3):593-8.

33. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, Deneffe GJ, Nackaerts KL, Verschakelen JA, Lerut TE, Mortelmans LA , Demedts MG. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16(6):2142-9.

34. Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, De Wever WF, Verbeken EK, Nuyts JL, Maes FP , Bogaert JG. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998; 25(11):1495-501.

35. Bury T, Dowlati A, Paulus P, Corhay JL, Hustinx R, Ghaye B, Radermecker M , Rigo P. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. Eur Respir J 1997; 10(11):2529-34.

36. Gdeedo A, Van Schil P, Corthouts B, Van Mieghem F, Van Meerbeeck J , Van Marck E. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Respir J 1997; 10(7):1547-51.

37. Buccheri G, Biggi A, Ferrigno D, Quaranta M, Leone A, Vassallo G , Pugno F. AntiCEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer. Thorax 1996; 51(4):359-63.

38. Bury T, Paulus P, Dowlati A, Corhay JL, Weber T, Ghaye B, Schoffers J, Limet R, Albert A, Rigo P , Radermecker M. Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer. Eur Respir J 1996; 9(12):2560-4.

39. Aaby C, Kristensen S , Nielsen SM. Mediastinal staging of non-small-cell lung cancer: computed tomography and cervical mediastinoscopy. ORL J Otorhinolaryngol Relat Spec 1995; 57(5):279-85.

40. Primack SL, Lee KS, Logan PM, Miller RR , Muller NL. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology 1994; 193(3):795800.

41. Yokoi K, Okuyama A, Mori K, Tominaga K, Miyazawa N, Takizawa I , Sasagawa M. Mediastinal lymph node metastasis from lung cancer: evaluation with Tl-201 SPECT-comparison with CT. Radiology 1994; 192(3):813-7.

42. McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JA, Moore EH, Wain JC, Mathisen DJ , Grillo HC. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182(2):319-23.

43. Jolly PC, Hutchinson CH, Detterbeck F, Guyton SW, Hofer B , Anderson RP. Routine computed tomographic scans, selective mediastinoscopy, and other factors in evaluation of lung cancer. J Thorac Cardiovasc Surg 1991; 102(2):266-70; discussion 270-1. 413

WWW.MEDLINE.RU ТОМ 7, ХИРУРГИЯ, НОЯБРЬ 2006

44. Cole PH, Roszkowski A, Firouz-Abadi A , Dare A. Computerised tomography does not predict N2 disease in patients with lung cancer. Aust N Z J Med 1993; 23(6):688-91.

45. McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JA, Moore EH, Wain JC, Mathisen DJ , Grillo HC. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182(2):319-23.

46. Кузнецов ИМ. Рак легкого, осложненный воспалительными и гнойнодеструктивными изменениями в легочной паренхиме и грудной полости [Автореферат диссертации на соискание ученой степени доктора медицинских наук]. Санкт-Петербург; 2005.

47. Eggeling S, Martin T, Bottger J, Beinert T , Gellert K. Invasive staging of non-small cell lung cancer--a prospective study. Eur J Cardiothorac Surg 2002; 22(5):679-84.